Michael Ryskin
Stock Analyst at B of A Securities
(1.48)
# 3,519
Out of 5,106 analysts
39
Total ratings
52%
Success rate
-1.14%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Upgrades: Buy | $24 | $18.81 | +27.59% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $97.58 | +1.46% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $64.72 | +8.16% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $682.31 | -30.38% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.29 | +143.16% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $156.76 | +31.41% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $102.50 | -60.98% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $1.97 | +382.23% | 1 | Jun 25, 2024 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $8.97 | +167.56% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $11.27 | +112.95% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $180 | $123.54 | +45.70% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.36 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $3.52 | +184.09% | 2 | Nov 10, 2021 |
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $18.81
Upside: +27.59%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $97.58
Upside: +1.46%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $64.72
Upside: +8.16%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $682.31
Upside: -30.38%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.29
Upside: +143.16%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $156.76
Upside: +31.41%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $102.50
Upside: -60.98%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $1.97
Upside: +382.23%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $8.97
Upside: +167.56%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $11.27
Upside: +112.95%
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $123.54
Upside: +45.70%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.36
Upside: -
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $3.52
Upside: +184.09%